ask="N/A"
ask_size="N/A"
average_daily_volume="556039"
bid="55.00"
bid_size="4900"
book_value="11.38"
change="-0.01"
change_from_200_day_moving_average="5.86"
change_from_50_day_moving_average="3.21"
change_from_52_week_high="-11.77"
change_From_52_week_low="28.48"
change_in_percent="-0.01%"
close="75.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="76.02"
high_52_weeks="86.77"
last_trade_date="2/1/2017"
last_trade_price="75.00"
last_trade_size="17381"
last_trade_time="4:00pm"
low="73.68"
low_52_weeks="46.52"
market_capitalization="3.06B"
moving_average_200_day="69.14"
moving_average_50_day="71.79"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="75.57"
pe_ratio="N/A"
peg_ratio="-0.37"
percent_change_from_200_day_moving_average="+8.48%"
percent_change_from_50_day_moving_average="+4.47%"
percent_change_from_52_week_high="-13.56%"
percent_change_from_52_week_low="+61.22%"
previous_close="75.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.59"
price_per_sales="23944.01"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="508658"
weeks_range_52="46.52 - 86.77"
